Fisetin suppresses cigarette smoke extract-induced epithelial to mesenchymal transition of airway epithelial cells through regulating COX-2/MMPs/β-catenin pathway

Chem Biol Interact. 2022 Jan 5:351:109771. doi: 10.1016/j.cbi.2021.109771. Epub 2021 Dec 2.

Abstract

Cigarette smoke exposure leads to upregulation of cyclooxygenase-2 (COX-2), an inducible enzyme that synthesizes prostaglandin E2 (PGE2) and promotes airway inflammation. COX-2 overexpression is frequently implicated in inflammation, invasion, metastasis, and epithelial-mesenchymal transition (EMT). However, its detailed molecular mechanism in cigarette smoke induced EMT is not clear. Further, fisetin, a bioflavonoid, exhibits antioxidant and anti-inflammatory properties, but its effect in modulating COX-2-mediated inflammation and downstream sequelae remains unexplored. Therefore, we have investigated the mechanism of cigarette smoke-induced COX-2-mediated EMT in airway epithelial cells and examined the role of fisetin in controlling this aberration. MTT, trypan blue staining, gelatin zymography, Western blotting, invasion, wound healing, and tumor sphere formation assays in cigarette smoke extract (CSE) and/or fisetin treated airway epithelial cells, and in-silico molecular docking studies were performed. Results revealed that CSE exposure increased the expression and activity of COX-2, MMP-2/9, and β-catenin and also enhanced expression of EMT markers leading to higher migration and invasion potential of airway epithelial cells. A specific COX-2 inhibitor NS-398 as well as fisetin treatment reversed the expression of EMT biomarkers, reduced the activity of MMP-2/9, and blocked the migration and invasion potential induced by CSE. Further, PGE2 also increased MMPs activity, invasion, and migration potential similar to CSE, which were significantly reversed by fisetin. In-silico studies showed a high binding affinity of fisetin to key EMT associated proteins, validating its anti-EMT potential. Thus, our study firstly unearths the mechanism of CSE-induced EMT in airway epithelial cells via COX-2/MMP/β-catenin pathway, and secondly, it reveals that fisetin could significantly reverse CSE-induced EMT by inhibiting COX-2, indicating that fisetin could be an effective drug candidate for cigarette smoke-induced lung dysfunction.

Keywords: Airway epithelial cells; COX-2; Cigarette smoke extract; EMT; Fisetin; Inflammation.

MeSH terms

  • A549 Cells
  • Cell Movement / drug effects
  • Cell Survival / drug effects
  • Cyclooxygenase 2 / metabolism
  • Epithelial Cells / drug effects*
  • Epithelial-Mesenchymal Transition / drug effects*
  • Flavonols / metabolism
  • Flavonols / pharmacology*
  • Humans
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase 9 / metabolism
  • Molecular Docking Simulation
  • Nicotiana / chemistry
  • Nitrobenzenes / pharmacology
  • Protein Binding
  • Signal Transduction / drug effects*
  • Sulfonamides / pharmacology
  • Tobacco Smoke Pollution / adverse effects*
  • beta Catenin / metabolism

Substances

  • CTNNB1 protein, human
  • Flavonols
  • Nitrobenzenes
  • Sulfonamides
  • Tobacco Smoke Pollution
  • beta Catenin
  • N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • MMP2 protein, human
  • Matrix Metalloproteinase 2
  • MMP9 protein, human
  • Matrix Metalloproteinase 9
  • fisetin